Erin Spiegel

Erin Spiegel, PhD, has extensive experience in regulatory affairs and scientific development within the medical device and biotechnology sectors. Currently serving as VP of Clinical and Regulatory Affairs at PharmaJet since February 2017 and VP of Regulatory and Quality at Transverse Medical Inc since January 2024, Erin has a strong background in regulatory and clinical strategy, medical device regulatory filings across the US, EU, and Canada, and quality assurance oversight. Previous roles include Senior Regulatory Affairs Specialist at Evergreen Research, Inc. and Scientific Consultant at CBR International Corp., where responsibilities encompassed project management, quality assurance for biotech companies, and regulatory compliance. Erin also worked as a Senior Scientist at Isogenis, Inc., where innovative methodologies for gene transfer vectors were developed, and earned a PhD in Biophysics and Genetics from the University of Colorado Anschutz Medical Campus.